Singapore markets closed

Rohto Pharmaceutical Co.,Ltd. (4527.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
3,264.00+19.00 (+0.59%)
At close: 03:15PM JST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
30,936,000
30,936,000
26,377,000
21,127,000
16,743,000
-
Depreciation & amortisation
8,687,000
8,687,000
7,801,000
7,689,000
6,748,000
-
Change in working capital
-8,877,000
-8,877,000
-11,277,000
776,000
3,402,000
-
Inventory
-4,029,000
-4,029,000
-6,105,000
-2,743,000
3,188,000
-
Other working capital
25,333,000
25,333,000
21,016,000
15,922,000
9,704,000
-
Other non-cash items
5,000
5,000
4,064,000
-1,951,000
-6,520,000
-
Net cash provided by operating activities
34,245,000
34,245,000
30,924,000
27,250,000
20,008,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-8,912,000
-8,912,000
-9,908,000
-11,328,000
-10,304,000
-
Acquisitions, net
-
-
0
-1,203,000
-1,516,000
-5,755,000
Purchases of investments
-9,080,000
-9,080,000
-5,940,000
-5,615,000
-2,206,000
-
Sales/maturities of investments
1,704,000
1,704,000
2,641,000
1,963,000
4,050,000
-
Other investing activities
230,000
230,000
178,000
128,000
-
112,000
Net cash used for investing activities
-16,317,000
-16,317,000
-13,176,000
-16,406,000
-10,237,000
-
Net change in cash
8,847,000
8,847,000
6,786,000
18,650,000
7,519,000
-
Cash at beginning of period
77,691,000
77,691,000
70,905,000
52,254,000
44,665,000
-
Cash at end of period
86,562,000
86,562,000
77,691,000
70,905,000
52,254,000
-
Free cash flow
Operating cash flow
34,245,000
34,245,000
30,924,000
27,250,000
20,008,000
-
Capital expenditure
-8,912,000
-8,912,000
-9,908,000
-11,328,000
-10,304,000
-
Free cash flow
25,333,000
25,333,000
21,016,000
15,922,000
9,704,000
-